APPLICATION NOTE
Imaging Mass Cytometry (IMC) Technology Uniquely Reveals Clinical Impact of HER2 Expression Levels
Download the application note now
Fill out the form below
Imaging Mass Cytometry (IMC) Technology Uniquely Reveals Clinical Impact of HER2 Expression Levels
Why the high dynamic range of IMC systems matters in spatial proteomics to capture biomarker insights from high and low protein expression
In this application note, we outline how:
- The high dynamic range of IMC technology empowers detection of high- and low-expressing markers
- Quantification of HER2 expression levels with IMC technology enables more precise tumor grading
- IMC technology enables association of tumor and immune cell phenotypes with quantitative spatial biomarker expression
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. All rights reserved.